Inpatient Penicillin Delabeling for Low-Risk Patients

Status Enrolling by invitation

Clinical Trial Summary

This study seeks to enroll patients admitted to a children's hospital with identified penicillin allergy. A screening checklist is performed to identify patients with very low or low risk histories of penicillin allergy to offer direct oral challenges to the antibiotic class to de-label patient's with drug allergies.

Clinical Trial Description

This is a pilot study looking to utilize a novel criterion to identify low risk penicillin allergies for patients admitted to a children's hospital to evaluate safety and efficacy of direct oral challenges to patients with very low or low risk histories as identified in novel criterion. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06414694
Study type	Interventional
Source	University of Tennessee
Contact
Status	Enrolling by invitation
Phase	Phase 4
Start date	September 1, 2023
Completion date	September 30, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05706246` - Perioperative Hypersensitivity in Children	N/A
Recruiting	`NCT04920721` - Retrospective Study of Immediate Hypersensitivity (IHS) Reactions to Platinum Salts in the University Hospital of Nancy
Completed	`NCT02118987` - Study of Omalizumab as Adjuvant Therapy in Chemotherapy Desensitization	Phase 1
Enrolling by invitation	`NCT03164044` - Improved Basophil Activation Test (BAT) in the Diagnostics of Drug Allergy
Completed	`NCT02094638` - Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study	N/A
Not yet recruiting	`NCT06399601` - A Training Program of Drug Allergy for Healthcare Professionals	N/A
Completed	`NCT03784482` - Multiple Drug Hypersensitivity Syndrome
Not yet recruiting	`NCT06406114` - Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing	Phase 2
Recruiting	`NCT05820802` - High Dimensional Analysis of Immune Cells in Pediatric Patients